Half of Gen Z Diagnosed with Depression Report Using Cannabis – Ganjapreneur | Where to order Skittles Moonrock online
Learn where to order cannabis online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
👉 Click here to Visit our shop! 🛒

Half of Gen Z who have been diagnosed with depression report consuming cannabis.
Full story after the jump.
Half of Gen Z who have been diagnosed with depression consume cannabis, according to a report released last week from precision psychiatry company NeuroKaire. Another 48% of Millennials, 41% of Gen X, and 22% of Boomers with a depression diagnosis surveyed also indicated either “regular” or “occasional” cannabis use.
Depressed individuals also used CBD products at higher rates that their non-depressed peers, with 59% more Gen Z with a depression diagnosis using CBD products (70% of depressed individuals compared to 44% of the full generation), along with 29% more Millennials (62% depressed, 48% full generation), 36% more Gen X (53% depressed, 42% full generation), and 69% more Boomers (44% depressed, 26% full generation). Seventy percent of depressed Gen Z indicated they were using CBD products specifically for mental wellness.
“Among Boomers with depression, regular marijuana use runs at about 12%, which seems low compared to Gen Z and Millennials, but that’s 71% more than their non-depressed Boomer peers (7%). This is the highest relative gap of any generation.” — NeuroKaire, “Self-Medication Generation”
In the report, NeuroKaire concludes that the cannabis survey data “reveals a population that is actively self-treating with plant-based substances and doing so with increasing intentionality.”
“The prevalence of marijuana use (which may serve multiple purposes) and CBD use specifically for mental wellness suggests that Americans with depression are not just using these substances recreationally,” the report states. “They are building treatment regimens outside of the clinical system.”
The report is based on a national survey of 18,341 U.S. adults fielded by Prosper Insights & Analytics and analyzed by NeuroKaire. Of that group, 3,737 reported having been diagnosed with depression.
TG joined Ganjapreneur in 2014 as a news writer and began hosting the Ganjapreneur podcast in 2016. He is based in upstate New York, where he also teaches media studies at a local university. More by TG Branfalt
Featured Subscriber:
Ganjapreneur is made possible by our business subscribers. Subscribe today
LATEST:


Leave a Reply
Want to join the discussion?Feel free to contribute!